Cleveland Clinic Research Finds Injectable Medications for Obesity Produce Smaller Weight Loss in A Real-World Setting, Compared to Randomized Clinical Trials
June 10, 2025
June 10, 2025
CLEVELAND, Ohio, June 10 [Category: BizHospital] -- The Cleveland Clinic posted the following news release:
* * *
Cleveland Clinic Research Finds Injectable Medications for Obesity Produce Smaller Weight Loss in A Real-World Setting, Compared to Randomized Clinical Trials
*
A Cleveland Clinic study shows that semaglutide and tirzepatide - injectable GLP-1 drugs for obesity - produce smaller weight loss in a real-world setting because patients d . . .
* * *
Cleveland Clinic Research Finds Injectable Medications for Obesity Produce Smaller Weight Loss in A Real-World Setting, Compared to Randomized Clinical Trials
*
A Cleveland Clinic study shows that semaglutide and tirzepatide - injectable GLP-1 drugs for obesity - produce smaller weight loss in a real-world setting because patients d . . .